Motofen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Sebela Pharmaceuticals Inc.. The primary component is Atropine Sulfate; Difenoxin Hydrochloride.
| Product ID | 54766-200_7cfe62d8-961c-5023-e053-2a91aa0a3575 |
| NDC | 54766-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Motofen |
| Generic Name | Difenoxin And Atropine Sulfate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-04-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017744 |
| Labeler Name | Sebela Pharmaceuticals Inc. |
| Substance Name | ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE |
| Active Ingredient Strength | 0 mg/1; mg/1 |
| Pharm Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Antidiarrheal [EPC] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-04-11 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| Marketing Category | NDA |
| Application Number | NDA017744 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-11 |
| Marketing Category | NDA |
| Application Number | NDA017744 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-04-11 |
| Ingredient | Strength |
|---|---|
| ATROPINE SULFATE | .025 mg/1 |
| SPL SET ID: | 4cd3f029-a5e3-5812-e054-00144ff8d46c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MOTOFEN 81023107 1023107 Dead/Cancelled |
Johnson & Johnson 0000-00-00 |
![]() MOTOFEN 73765421 1552470 Live/Registered |
CARNRICK LABORATORIES, INC. 1988-11-23 |